Form 25-NSE Sagent Pharmaceuticals, Filed by: NASDAQ Stock Market LLC

    X0203

    
        0001354457
        NASDAQ Stock Market LLC
    

    
        0001369786
        Sagent Pharmaceuticals, Inc.
        001-35144
        

            1901 North Roselle Road, Suite 700
            
            Shaumburg
            IL
            ILLINOIS
            60195
        
        (847) 908-1600
    

    Common Stock

    17 CFR 240.12d2-2(a)(3)

    
        Tara Petta
        Director
        2016-08-29
    

sgnt-form25

You May Also Be Interested In

• Fastwyre Broadband Begins Its Initial Investment in Central Alabama Bringing Its Fiber Optic Network to the Region
• Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
• Completion of Largest Capacity GMP Run Marks New Standard in Biologics Manufacturing